ESG risk score 32.26
Environmental score 5.74
Social score 20.79
Governance score 5.72
ESG risk category High
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
PureTech Health Plc
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol PRTC:xlon
Currency GBP
London Stock Exchange
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) -9.6%
1 year -20.42%
3 years -48.98%
Data provided by 
Key stats
Price/earnings (LTM) 7.91
Dividend yield (LTM) -
EPS (LTM) 14.29
Volatility (30 days) 23.25%
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About PureTech Health Plc
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
Sector Healthcare
Industry -
Market cap 0.276522848bn
Data provided by /
/ Frequently asked questions
To buy PureTech Health Plc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for PureTech Health Plc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for PureTech Health Plc is PRTC:xlon. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
PureTech Health Plc has its primary listing on London Stock Exchange. You can trade PureTech Health Plc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, PureTech Health Plc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include PureTech Health Plc as part of a broader investment portfolio.